535
Participants
Start Date
March 31, 2014
Primary Completion Date
June 30, 2015
Study Completion Date
June 30, 2015
Ibodutant 10 mg
Oral tablet, to be given once daily.
Placebo
Oral tablet, (identical in appearance and weight to ibodutant tablets), to be given once daily.
Sofia
Sofia
Plovdiv
Veliko Tarnovo
Haskovo
Rousse
Mataró
Hartsdale
Berlin
Berlin
Prague
Prague
Reading
Bucharest
Hamburg
Baltimore
Hamburg
Morgantown
Pavia
Greensboro
Madrid
Fayetteville
Greer
Simpsonville
Krakow
Gainesville
Bordeaux
Hialeah
Miami Lakes
Miami
Coral Gables
Miami
Miami
Miami
Boynton Beach
Jupiter
Brandon
Brooksville
Huntsville
Smyrna
Nashville
Chattanooga
Knoxville
Knoxville
Bologna
Lexington
Seville
Owensboro
Madisonville
Columbus
Nantes
Cleveland
Akron
Cincinnati
Cincinnati
Essen
Dayton
Chesterfield
Troy
Ann Arbor
Saginaw
Bucharest
Florence
Wroclaw
Fargo
Addison
Chicago
Augusta
Newton
Wichita
Bari
Bari
Crowley
Stuttgart
Sherwood
Little Rock
Rouen
Hurst
Houston
Houston
Ste. Channelview
Beaumont
San Antonio
Littleton
West Jordan
Las Vegas
Artesia
Mission Hills
Encino
Upland
Chula Vista
San Diego
Bobigny
Sacramento
Moscow
Yaroslavl
Saint Petersburg
Saint Petersburg
Saint Petersburg
Smolensk
Kaluga
Timișoara
Timișoara
Brasov
Brasov
Târgu Mureş
Târgu Mureş
Bristol
Karlovy Vary
Ústí nad Labem
Ústí nad Orlicí
Nice
Rome
Bydgoszcz
Częstochowa
Lublin
Badalona
Sabadell
Barcelona
Barcelona
Penzance
Chesterfield
Inverness
Doncaster
Leicestershire
Manchester
Plymouth, Devon
Lead Sponsor
Menarini Group
INDUSTRY